Cargando…
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Type 2 diabetes (T2D) has a heterogeneous etiology influencing its progression, treatment, and complications. A data driven cluster analysis in European individuals with T2D previously identified four subtypes: severe insulin deficient (SIDD), severe insulin resistant (SIRD), mild obesity-related (M...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675829/ https://www.ncbi.nlm.nih.gov/pubmed/36402758 http://dx.doi.org/10.1038/s41467-022-34754-z |
_version_ | 1784833457623400448 |
---|---|
author | Zaghlool, Shaza B. Halama, Anna Stephan, Nisha Gudmundsdottir, Valborg Gudnason, Vilmundur Jennings, Lori L. Thangam, Manonanthini Ahlqvist, Emma Malik, Rayaz A. Albagha, Omar M. E. Abou‑Samra, Abdul Badi Suhre, Karsten |
author_facet | Zaghlool, Shaza B. Halama, Anna Stephan, Nisha Gudmundsdottir, Valborg Gudnason, Vilmundur Jennings, Lori L. Thangam, Manonanthini Ahlqvist, Emma Malik, Rayaz A. Albagha, Omar M. E. Abou‑Samra, Abdul Badi Suhre, Karsten |
author_sort | Zaghlool, Shaza B. |
collection | PubMed |
description | Type 2 diabetes (T2D) has a heterogeneous etiology influencing its progression, treatment, and complications. A data driven cluster analysis in European individuals with T2D previously identified four subtypes: severe insulin deficient (SIDD), severe insulin resistant (SIRD), mild obesity-related (MOD), and mild age-related (MARD) diabetes. Here, the clustering approach was applied to individuals with T2D from the Qatar Biobank and validated in an independent set. Cluster-specific signatures of circulating metabolites and proteins were established, revealing subtype-specific molecular mechanisms, including activation of the complement system with features of autoimmune diabetes and reduced 1,5-anhydroglucitol in SIDD, impaired insulin signaling in SIRD, and elevated leptin and fatty acid binding protein levels in MOD. The MARD cluster was the healthiest with metabolomic and proteomic profiles most similar to the controls. We have translated the T2D subtypes to an Arab population and identified distinct molecular signatures to further our understanding of the etiology of these subtypes. |
format | Online Article Text |
id | pubmed-9675829 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-96758292022-11-21 Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population Zaghlool, Shaza B. Halama, Anna Stephan, Nisha Gudmundsdottir, Valborg Gudnason, Vilmundur Jennings, Lori L. Thangam, Manonanthini Ahlqvist, Emma Malik, Rayaz A. Albagha, Omar M. E. Abou‑Samra, Abdul Badi Suhre, Karsten Nat Commun Article Type 2 diabetes (T2D) has a heterogeneous etiology influencing its progression, treatment, and complications. A data driven cluster analysis in European individuals with T2D previously identified four subtypes: severe insulin deficient (SIDD), severe insulin resistant (SIRD), mild obesity-related (MOD), and mild age-related (MARD) diabetes. Here, the clustering approach was applied to individuals with T2D from the Qatar Biobank and validated in an independent set. Cluster-specific signatures of circulating metabolites and proteins were established, revealing subtype-specific molecular mechanisms, including activation of the complement system with features of autoimmune diabetes and reduced 1,5-anhydroglucitol in SIDD, impaired insulin signaling in SIRD, and elevated leptin and fatty acid binding protein levels in MOD. The MARD cluster was the healthiest with metabolomic and proteomic profiles most similar to the controls. We have translated the T2D subtypes to an Arab population and identified distinct molecular signatures to further our understanding of the etiology of these subtypes. Nature Publishing Group UK 2022-11-19 /pmc/articles/PMC9675829/ /pubmed/36402758 http://dx.doi.org/10.1038/s41467-022-34754-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Zaghlool, Shaza B. Halama, Anna Stephan, Nisha Gudmundsdottir, Valborg Gudnason, Vilmundur Jennings, Lori L. Thangam, Manonanthini Ahlqvist, Emma Malik, Rayaz A. Albagha, Omar M. E. Abou‑Samra, Abdul Badi Suhre, Karsten Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title | Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title_full | Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title_fullStr | Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title_full_unstemmed | Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title_short | Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population |
title_sort | metabolic and proteomic signatures of type 2 diabetes subtypes in an arab population |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675829/ https://www.ncbi.nlm.nih.gov/pubmed/36402758 http://dx.doi.org/10.1038/s41467-022-34754-z |
work_keys_str_mv | AT zaghloolshazab metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT halamaanna metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT stephannisha metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT gudmundsdottirvalborg metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT gudnasonvilmundur metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT jenningsloril metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT thangammanonanthini metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT ahlqvistemma metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT malikrayaza metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT albaghaomarme metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT abousamraabdulbadi metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation AT suhrekarsten metabolicandproteomicsignaturesoftype2diabetessubtypesinanarabpopulation |